TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has issued an update.
Piramal Pharma Limited has issued a corporate guarantee for its subsidiaries, Piramal Dutch Holdings N.V. and PPL Pharma Inc., to secure financing arrangements worth USD 216 million. This transaction, conducted on an arm’s length basis, is currently a contingent liability and has no immediate impact on the company’s financial status or stakeholder interests.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. It provides services and solutions to various sectors, including healthcare, research, and therapeutic areas, with a market focus on innovation and global reach.
YTD Price Performance: -6.29%
Average Trading Volume: 532,319
Current Market Cap: 320.7B INR
See more insights into PPLPHARMA stock on TipRanks’ Stock Analysis page.